CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-11.33%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$742M
AUM Growth
+$742M
(-18%)
Cap. Flow
-$36.1M
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
45.48%
Holding
92
New
8
Increased
13
Reduced
17
Closed
15
Top Buys
| 1 |
KA
Kineta, Inc. Common Stock
KA
|
$17.8M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.2M |
| 3 |
Theravance Biopharma
TBPH
|
$9.78M |
| 4 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$9.14M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$7.99M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$23.4M |
| 2 |
MacroGenics
MGNX
|
$21.2M |
| 3 |
CLLS
Cellectis
CLLS
|
$12M |
| 4 |
ADXS
Advaxis, Inc.
ADXS
|
$9.85M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$8.55M |
Sector Composition
| 1 | Healthcare | 91.34% |
